WHO ICTRP trial
Evaluation of N-acetylcysteine in treatment of chronic hemodialysis patients
IRCT201201108679N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201201108679N1 |
|---|---|
| Public title | Evaluation of N-acetylcysteine in treatment of chronic hemodialysis patients |
| Scientific title | Evaluation of N-acetylcysteine in reduction of serum total oxidative stress in comparison with placebo in chronic hemodialysis patients |
| Primary sponsor | Vice Chancellor for Development, Research and Technology of Ahvaz Jondishapour University of Medical |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Condition 1: Hemodialysis patients. Condition 2: Hemodialysis patients. Condition 3: Hemodialysis patients. Renal failure Renal failure Renal failure;Renal failure;Renal failure;Renal failure |
| Interventions | Intervention 1: Control Group: Placebo as 600 milligram tablet, twice daily, every 12 hours, per oral for 6 weeks, made from micro-crystalline cellulose, lactose, corn starch, sorbitol, talk (2% of total tablet weight) which made in… |
| Registration date | May 17, 2013 |
| Target size | 40 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: